Does pill testing mean the NSW government is endorsing drug use?

No. The NSW Health Minister has explicitly stated the program is not an endorsement of drug use. It is a harm minimisation measure — the same framework that governs needle and syringe programs in Australia. The evidence from the 12-month trial shows reduced drug-related hospital presentations, not increased drug uptake.

What does this mean for GPs when patients mention festival drug use?

The RACGP NSW Chair, Dr Rebekah Hoffman, has called for GPs to be formal referral endpoints from pill testing services. In practice: if a patient discloses festival drug use, this is a harm reduction conversation, not a disciplinary one. Your role is to understand what they took, assess for any adverse effects, and connect them with regular care. This is general practice harm reduction — it belongs in the consultation.

NSW makes pill testing permanent — what GPs need to know

What just happened

The NSW government has announced that drug checking services will become a permanent feature at up to 15 music festivals annually, funded by $4.3 million following a 12-month trial that ran from March 2025 to March 2026. The service — free, anonymous, and testing for purity, potency, and adulterants — will begin the expanded rollout in October.

The trial was independently evaluated by the University of Sydney. Results: over 1,800 individuals accessed services, approximately 1,500 samples were tested, and drug-related hospital presentations dropped from an average of 3.6 per festival day in the two years before the trial, to 2.3 per festival day during it. Four festivals recorded zero drug-related presentations. Of the people who discovered unexpected substances in their samples, 30% discarded them entirely and 37.5% reduced how much they took.

The RACGP has endorsed the decision and is pushing for the next step: positioning GPs as formal referral endpoints.

This is worth knowing about for any GP who sees young adults, parents of them, or people who attend festivals.

The both-and

Why the evidence matters here

Pill testing is not a new idea. Needle and syringe programs were contested in exactly the same terms in the 1980s — enabling use, sending the wrong message — and the evidence eventually settled the debate. The pilot data from NSW is early but directionally consistent with what European drug checking programs have documented for years: people who know what they are taking make different decisions about whether and how much to take.

The 8.1% unexpected substance rate in the trial data is not alarming — it is clarifying. Roughly 1 in 12 samples contained something the user did not expect. Some of those surprises were dangerous adulterants; others were mislabelled dosages. The service converts an unknown risk into an informed one. That is what public health infrastructure does.

The comparison figure — 3.6 hospital presentations per festival day before, 2.3 during — represents fewer people in emergency departments and fewer families navigating a crisis in a festival medical tent. Whether that reduction is directly attributable to drug checking services alone (other factors may have changed across festivals) will be debated in the peer-reviewed literature. But the trial evaluation’s finding is consistent with reduced harm, not harm transfer.

What is genuinely uncertain

The evaluation was not randomised. Festival-to-festival variation is real, and the comparator baseline involved different events across different years. Prof. David Caldicott, one of Australia’s foremost harm reduction voices, called the decision “a great move” while questioning whether the funding scale matches the scope of the problem — particularly given that most drug-related deaths do not occur at festivals, they occur in homes.

That is the honest tension: festival pill testing reaches a visible, concentrated setting but may miss the majority of people at highest risk. The RACGP NSW Chair, Dr Rebekah Hoffman, has already called for the service to expand into community settings beyond festivals. That conversation is the logical next frontier.

The program also does not change the legal status of drug possession. Police enforcement, charge decisions, and the interface between harm reduction services and law enforcement remain contested terrain — and GPs operating in festival settings or receiving referrals from them are navigating a complex medico-legal space.

My two cents

Most GPs in Australia already navigate harm reduction in every consultation involving alcohol, tobacco, and prescribed opioids. Drug checking at festivals extends that same framework to a different setting and a population that is often young, healthy, and otherwise disconnected from general practice.

Dr Rebekah Hoffman’s call for GPs to be positioned as safe landing points from pill testing services is the right instinct. It is also worth noting: you do not need a formal referral pathway to start doing this. If a patient mentions they are going to a festival, or they disclose recreational drug use in a consultation, that is already your opening. The conversation costs you nothing and may matter enormously.

For those of us with patients who are parents of festival-going young adults: this is also a conversation for them. Understanding what pill testing is — and what it is not — makes it easier to have an honest conversation with a young person before they go.

Verdict: yes — the evidence is directional and the RACGP endorsement is appropriate. General practice has a role here, whether or not formal referral pathways exist yet.

Sources cited

NSW pill testing ‘a step in the right direction’, RACGP says — Medical Republic, 2 September 2026. https://www.medicalrepublic.com.au/nsw-pill-testing-a-step-in-the-right-direction-racgp-says/128684
NSW government to make pill testing permanent after successful trial — ABC News, 2 September 2026. https://www.abc.net.au/news/2026-09-02/pill-testing-to-continue-at-nsw-music-festivals-after-trial/107103918